id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-297125-la20vi9j	Brower, Jennifer L.	The Threat and Response to Infectious Diseases (Revised)	2016-08-01		.txt	text/plain	12334	579	44	In just the past year, the United States has been bombarded with headlines on the dangers of infectious diseases: "HIV 'Epidemic' Triggered by Needle-Sharing Hits Scott County, Indiana [1] ;" "American with Ebola Now in Critical Condition [2] ;" "Seasonal Flu Vaccine Even Less Effective than Thought: CDC [3] ;" "'Superbug' Outbreak at California Hospital, more than 160 Exposed [4] ;" "Deadly CRE Bugs Linked to Hard to Clean Medical Scopes [5] ;" "Painful Virus [Chikungunya] Sweeps Central America, Gains a Toehold in U.S. Many factors have reduced the number of new antibiotics approved in the United States each year as well as reduced domestic production including demanding Food and Drug Administration (FDA) regulations, the cost and time to market of development, the consolidation in the pharmaceutical industry, and the lack of financial impetus to produce and distribute antibiotics, which are generally used on a one-off basis versus drugs used to treat chronic conditions such as statins, Viagra, and allergy medications.	./cache/cord-297125-la20vi9j.txt	./txt/cord-297125-la20vi9j.txt